Livzon Pharmaceutical Group Inc. 麗珠醫藥集團股份有限公司 has announced that its Board of Directors will convene on 24 March 2026. The meeting will focus on reviewing and approving the annual results for the financial year ended 31 December 2025, as well as considering a possible final dividend. Any additional business deemed necessary will also be addressed.
According to the announcement dated 2 March 2026, the Board of Livzon Pharmaceutical Group Inc. includes Executive Directors, Non-Executive Directors, an Employee Representative Director, and Independent Non-Executive Directors.